Ketogenic diet – effective treatment of childhood and adolescent epilepsies

Czech version

Authors: O. Horák
Authors‘ workplace: Klinika dětské neurologie LF MU a FN Brno Centrum pro epilepsie Brno
Published in: Cesk Slov Neurol N 2019; 82(1): 8-14
Category: Minimonography
doi: https://doi.org/10.14735/amcsnn20198

Overview

Ketogenic diet has been established in the treatment of epilepsy for almost 100 years. It is irreplaceable in paediatric epileptology, especially in the treatment of myoclonic-atonic epilepsy, making it the most effective therapeutic option. With growing knowledge and implementation of the modified Atkins diet and the low glycaemic index treatment in clinical practice, the usage of ketotherapy, which is an umbrella term for all dietary regimes based on carbohydrate restriction and fat surplus, has been extended to all age brackets of epilepsy patients. Nevertheless, it is still a highly-selective therapy, specified for an exclusive circle of patients with perfect compliance, which is fundamental for clinical success. This work aims to provide an overview of current knowledge in the field of ketotherapy and to provide clinicians with the insight into the important practical aspects of its management.

Key words:

ketotherapy – ketogenic – diet – intractable epilepsy

The author declares he has no potential conflicts of interest concerning drugs, products, or services used in the study.

The Editorial Board declares that the manuscript met the ICMJE “uniform requirements” for biomedical papers.

Sources

1. Guelpa G, Marie A. La lutte contre l`epilepsie par la desintoxication et par la reducation alimentaire. Rev Ther Medico-Chirurgicale 1911; 78: 8– 13.
2. Geyelin HR. Fasting as a method for treating epilepsy. Medical Record 1921; 99: 1037– 1039.
3. Conklin HW. Cause and treatment of epilepsy. J Am Osteopath Assoc 1922; 26: 11– 14.
4. Woodyatt RT. Objects and method of diet adjustment in diabetes. Arch Intern Med 1921; 38(2): 125– 141.
5. Wilder RM. The effect of ketonemia on the course of epilepsy. Mayo Clin Proc 1921; 2: 307.
6. Wilder RM. High fat diets in epilepsy. Mayo Clin Proc 1921; 2: 308.
7. Huttenlocher PR, Wilbourne AJ, Sigmore JM. Medium chain triglycerides as a therapy for intractable childhood epilepsy. Neurology 1921; 21(11): 536– 540.
8. Neal EG, Chaffe HM, Schwartz R et al. A randomised trial of classical and medium-chain triglyceride ketogenic diets in the treatment of childhood epilepsy. Epilepsia 2009; 50(5): 1109– 1117. doi: 10.1111/ j.1528-1167.2008.01870.x.
9. Kossoff EH, Rowley H, Sinha SR et al. A prospective study of the modified Atkins diet for intractable epilepsy in adults. Epilepsia 2008; 49(2): 316– 319. doi: 10.1111/ j.1528-1167.2007.01256.x.
10. Kossoff EH, Bosarge JL, Miranda MJ et al. Will seizure controle improve by switching the modified Atkins diet to the traditional ketogenic diet? Epilepsia 2010; 51(12): 2496– 2499. doi: 10.1111/ j.1528-1167.2010.02774.x.
11. Pfeifer HH, Thiele EA. Low-glycaemic index treatment: a liberalized ketogenic diet for treatment of intractable epilepsy. Neurology 2005; 65(11): 1810– 1812. doi: 10.1212/ 01.wnl.0000187071.24292.9e.
12. Kossoff EH, Zupec-Kania BA, Auvin S et al. Optimal clinical management of children receiving dietary therapies for epilepsy: Updated recommendations of the International Ketogenic Diet Study Group. Epilepsia Open 2018; 3(2): 175– 192. doi: 10.1002/ epi4.12225.
13. Wolover T, Jenkins D. Effect of dietary fiber and foods on carbohydrate metabolism. In: Spiller G (ed). Handbook of dietary fiber in human nutrition. 3rd ed. Boca Raton, FL: CRP Press 2001: 321– 362.
14. Brand-Miller J, Holt S. Testing the glycaemic index of foods: in vivo, not in vitro. Eur J Clin Nutr 2004; 58(4): 700– 701. doi: 10.1038/ sj.ejcn.1601856.
15. Hartman AL, Rho JM. The biochemical basis of dietary therapies for neurological disorders. In: Neal E (ed). Dietary treatment of epilepsy. Chichester: John Wiley and Sons, Ltd 2012: 34– 44.
16. Rho JM. How does the ketogenic diet induce anti-seizure effects? Neurosci Lett 2017; 10(637): 4– 10. doi: 10.1016/ j.neulet.2015.07.034.
17. Rho JM, Anderson GD, Donevan SD et al.Acetoacetate, acetone and dibenzylamine (a concomitant in 1-(+)-beta-hydroxybutyrate) exhibit direct anticonvulsant actions in vivo. Epilepsia 2002; 43(4): 358– 361.
18. Thio LL, Wong M, Yamada KA. Ketone bodies do not directly alter excitatory or inhibitory hippocampal synaptic transmission. Neurology 2000; 54: 325-331. doi: 10.1212/ wnl.54.2.325
19. McDaniel SS, Rensing NR, Thio LL et al. The ketogenic diet inhibits the mammalian terget of rapamycin (mTOR) pathway. Epilepsia 2011; 52(3): e7– e11. doi: 10.1111/ j.1528-1167.2011.02981.x.
20. Yudkoff M, Daikhin Y, Horyn O et al. Ketosis and brain handling of glutamate, glutamine, and GABA. Epilepsia 2008; 49 (Suppl 8): 73– 75. doi: 10.1111/ j.1528-1167.2008.01841.x.
21. Hassan-Olive MM, Lauritzen KH, Ali M et al. A ketogenic diet improves mitochondrial biogenesis and bioenergetics via tha PGC1α-SIRT3-UCP2 Axis. Neurochem Res 2018; [Epub ahead of print]. doi: 10.1007/ s11064-018-2588-6.
22. Gaspard N, Hirsch LJ, Sculier C et al. New-onset refractory status epilepticus (NORSE) and febrile infection-related epilepsy syndrome (FIRES): state of the art and perspectives. Epilepsia 2018; 59(4): 745– 752. doi: 10.1111/ epi.14022.
23. Freeman JM, Vining EP, Pillas DJ et al. The efficacy of the ketogenic diet-1998: a prospective evaluation of intervention in 150 children. Pediatrics 1998; 102(6): 1358– 1363.
24. Lefevre F, Aronson N. Ketogenic diet for treatment of refraktory epilepsy in children: a systematic review of efficacy. Pediatrics 2000; 105(4): E46.
25. Bergqvist AG, Schall JI, Gallagher PR et al. Fasting versus gradual initiation of the ketogenic diet: a prospective, randomized clinical trial of efficacy. Epilepsia 2005; 46(11): 1810– 1819. doi: 10.1111/ j.1528-1167.2005.00282.x.
26. Freeman JM, Vining EP, Kossoff EH et al. A blinded, crossover study of the efficacy of the ketogenic diet. Epilepsia 2009; 50(2): 322– 325. doi: 10.1111/ j.1528-1167.2008.01740.x.
27. Sharma S, Sankhyan N, Gulati S et al. Use of the modified Atkins diet for the treatment of refractory childhood epilepsy: a randomized controlled trial. Epilepsia 2013; 54(3): 481– 486. doi: 10.1111/ epi.12069.
28. Lambrechts DA, de Kinderen RJ, Vles JS et al. A randomized controlled trial of the ketogenic diet in refraktory childhood epilepsy. Acta Neuol Scand 2017; 135(6): 231– 239. doi: 10.1111/ ane.12737.
29. Chen W, Kossoff EH. Long-term follow-up of children treated with the modified Atkins diet. J Child Neurol 2012; 27(6): 754– 758. doi: 10.1177/ 0883073812441062.
30. Ye F, Li XJ, Jiang WL et al. Efficacy of and patient compliance with ketogenic diet in adults with intractable epilepsy: a metaanalysis. J Clin Neuol 2015; 11(1): 26– 31. doi: 10.3988/ jcn.2015.11.1.26.
31. van der Louw E, van den Hurk D, Neal E et al. Ketogenic diet guidelines for infants with refraktory epilepsy. Eur J Paediatr Neurol 2016; 20(6): 798– 809. doi: 10.1016/ j.ejpn.2016.07.009.
32. Buchhalter JR, D`Alfonso S, Connolly M et al. The relationship between D-beta-hydroxybutyrate blood concentrations and seizure control in children treated with the ketogenic diet for medically intractable epilepsy. Epilepsia Open 2017; 2(3): 317– 321. doi: 10.1002/ epi4.12058.
33. Kossoff EH, Laux LC, Blackford R et al. When do seizures esually improve with the ketogenic diet? Epilepsia 2008; 49(2): 329– 333. doi: 10.1111/ j.1528-1167.2007.01417.x.
34. Martinez CC, Pyzik PL, Kossoff EH. Discontinuing the ketogenic diet in seizure-free children: recurrence and risk factors. Epilepsia 2007; 48(1): 187– 190. doi: 10.1111/ j.1528-1167.2006.00911.x.
35. Nizamuddin J, Turner Z, Rubenstein JE et al. Management and risk factors for dyslipidemia with the ketogenic diet. J Child Neurol 2008; 23(7): 758– 761. doi: 10.1177/ 0883073808318061.
36. Güzel O, Yilmaz U, Uysal U et al. The effect of olive oil-based ketogenic diet on serum lipid levels in epileptic children. Neurol Sci 2016; 37(3): 465– 470. doi: 10.1007/ s10072-015-2436-2.
37. Kwiterovich PO Jr, Vining EP, Pyzik P et al. Effect of a high-fat ketogenic diet on plasma levels of lipids, lipoproteins, and apolipoproteins in children. JAMA 2003; 290(7): 912– 920. doi: 10.1001/ jama.290.7.912.
38. Groesbeck DK, Bluml RM, Kossoff EH. Long-term use of the ketogenic diet in the treatment of epilepsy. Dev Med Child Neurol 2006; 48(12): 978– 981. doi: 10.1017/ S0012162206002143.
39. Doksöz Ö, Güzel O, Yilmax Ü et al. The short-term effect of ketogenic diet on carotid intima-media thickness and elastic properties of the carotid artery and aorta in epileptic children. J Child Neurol 2015; 30(12): 1646– 1650. doi: 10.1177/ 0883073815576793.
40. Coppola G, Natale F, Torino A et al. The impact of the ketogenic diet on arterial morphology and endothelial function in children and young adults with epilepsy: a case-control study. Seizure 2014; 23(4): 260– 265. doi: 10.1016/ j.seizure.2013.12.002.
41. Sampath A, Kossoff EH, Furth SL et al. Kidney stones and the ketogenic diet: risk factors and prevention. J Child Neurol 2007; 22(4): 375– 378. doi: 10.1177/ %883073807301926.
42. Furth SL, Casey JC, Pyzik PL et al. Risk factors for urolithiasis in children on the ketogenic diet. Pediatr Nephrol 2000; 15(1– 2): 125– 128.
43. Vining EP, Pyzik P, McGrogan J et al. Growth of children on the ketogenic diet. Dev Med Child Neurol 2002; 44(12): 796– 802. doi: 10.1111/ j.1469-8749.2002.tb00769.x.
44. Stewart WA, Gordon K, Camfield P. Acute pancreatitis causing death in a child on the ketogenic diet. J Child Neurol 2001; 16(9): 682. doi: 10.1177/ 08830738010 1600910.
45. Best TH, Franz DN, Gilbert DL et al. Cardiac complications in pediatric patients on the ketogenic diet. Neurology 2000; 54(12): 2328– 2330. doi: 10.1212/ WNL.54.12.2328.